These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28835775)

  • 21. Performance evaluation of NeuMoDx 96 system for hepatitis B and C viral load.
    Chooramani G; Samal J; Rani N; Singh G; Agarwal R; Bajpai M; Kumar M; Prasad M; Gupta E
    World J Virol; 2023 Sep; 12(4):233-241. PubMed ID: 37970568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Transcription-Mediated Amplification and Real-Time PCR Assays for Hepatitis B Virus DNA Quantitation in Serum.
    Weber J; Sahoo MK; Taylor N; Uy E; Shi RZ; Pinsky BA
    J Appl Lab Med; 2019 Nov; 4(3):383-390. PubMed ID: 31659075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy.
    Mücke MM; Maasoumy B; Dietz J; Mücke VT; Simon CO; Canchola JA; Cornberg M; Marins EG; Manns MP; Zeuzem S; Wedemeyer H; Sarrazin C; Vermehren J
    PLoS One; 2019; 14(11):e0224751. PubMed ID: 31738773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test.
    Pierce VM; Eversley JS; Tran TK; Rosenberg ES
    Clin Chem Lab Med; 2017 Jun; 55(7):956-961. PubMed ID: 27988503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance Evaluation of the Aptima Assays in Comparison with the cobas 6800 Assays for the Detection of HIV-1, HBV, and HCV in Clinical Samples.
    Park Y; Roh J; Kim S
    Ann Lab Med; 2022 Jul; 42(4):447-456. PubMed ID: 35177565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.
    Taylor N; Haschke-Becher E; Greil R; Strasser M; Oberkofler H
    Antivir Ther; 2014; 19(5):449-54. PubMed ID: 24430620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid quantification assay of hepatitis B virus DNA in human serum and plasma by Fully Automated Genetic Analyzer μTASWako g1.
    Watanabe M; Toyoda H; Kawabata T
    PLoS One; 2023; 18(2):e0278143. PubMed ID: 36758029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Highly Prevalent Polymorphism in the Core Region Impairs Quantification of Hepatitis B Virus (HBV) by the cobas TaqMan HBV Assay.
    Boizeau L; Servant-Delmas A; Ducancelle A; Chevaliez S; Thibault V; Laperche S; Cappy P
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32669381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.
    Vermehren J; Maasoumy B; Maan R; Cloherty G; Berkowski C; Feld JJ; Cornberg M; Pawlotsky JM; Zeuzem S; Manns MP; Sarrazin C; Wedemeyer H
    Clin Infect Dis; 2016 May; 62(10):1228-1234. PubMed ID: 26908802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multi-center clinical study comparing Sansure Magb and CAP/CTM HBV tests in the quantitative detection of HBV DNA.
    Fu X; Tan D; Dou X; Chen J; Wu J
    J Infect Dev Ctries; 2016 Aug; 10(7):755-61. PubMed ID: 27482808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v1.0 with v2.0 in HIV-1 viral load quantification.
    Tung YC; Ke LY; Lu PL; Lin KH; Lee SC; Lin YY; Chou LC; Tsai WC
    Kaohsiung J Med Sci; 2015 Apr; 31(4):188-93. PubMed ID: 25835274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.
    Kessler HH; Cobb BR; Wedemeyer H; Maasoumy B; Michel-Treil V; Ceccherini-Nelli L; Bremer B; Hübner M; Helander A; Khiri H; Heilek G; Simon CO; Luk K; Aslam S; Halfon P
    J Clin Virol; 2015 Jun; 67():67-72. PubMed ID: 25959162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analytical performance of the Hologic Aptima HBV Quant Assay and the COBAS Ampliprep/COBAS TaqMan HBV test v2.0 for the quantification of HBV DNA in plasma samples.
    Schønning K; Johansen K; Nielsen LG; Weis N; Westh H
    J Clin Virol; 2018 Jul; 104():83-88. PubMed ID: 29783147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assay.
    Fourati S; Challine D; Poveda JD; Laperche S; Rallier S; Pawlotsky JM; Chevaliez S
    J Clin Virol; 2017 Jul; 92():69-74. PubMed ID: 28549336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep/COBAS Taqman and Abbott RealTime Test assays for quantification of hepatitis C virus and HIV RNA.
    Wolff D; Gerritzen A
    Clin Chem Lab Med; 2007; 45(7):917-22. PubMed ID: 17617038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multisite Performance Evaluation of the cobas 5800 System and Comparison to the cobas 6800/8800 Systems for Quantitative Measurement of HBV, HCV, and HIV-1 Viral Load.
    Tschäpe J; Cobernuss-Rahn A; Boyle S; Parkin N; LaBrot B; Aslam S; Young S; Gohl P
    Microbiol Spectr; 2022 Dec; 10(6):e0312522. PubMed ID: 36314963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter evaluation of the cobas® HIV-1 quantitative nucleic acid test for use on the cobas® 4800 system for the quantification of HIV-1 plasma viral load.
    Adams P; Vancutsem E; Nicolaizeau C; Servais JY; Piérard D; François JH; Schneider T; Paxinos EE; Marins EG; Canchola JA; Seguin-Devaux C
    J Clin Virol; 2019 May; 114():43-49. PubMed ID: 30991164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya.
    Zeh C; Ndiege K; Inzaule S; Achieng R; Williamson J; Chih-Wei Chang J; Ellenberger D; Nkengasong J
    PLoS One; 2017; 12(6):e0179316. PubMed ID: 28622370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A European multicientre study on the comparison of HBV viral loads between VERIS HBV assay and Roche COBAS
    Braun P; Delgado R; Drago M; Fanti D; Fleury H; Izopet J; Lombardi A; Marcos M; Sauné K; O'Shea S; Pérez-Rivilla A; Ramble J; Trimoulet P; Vila J; Whittaker D; Artus A; Rhodes D
    J Clin Virol; 2017 Oct; 95():76-83. PubMed ID: 28892764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China.
    Xu S; Song A; Nie J; Li X; Meng S; Zhang C; Wang Y
    J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.